Navigation Links
Optimer to Provide DIFICID™ Launch Update at Morgan Stanley Global Healthcare Conference
Date:9/12/2011

SAN DIEGO, Sept. 12, 2011 /PRNewswire/ -- Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) announced that the Company will provide an update on the DIFICID™ (fidaxomicin) tablets launch at the Morgan Stanley Global Healthcare Conference taking place in New York City. Pedro Lichtinger, Optimer's President and CEO, will comment on the DIFICID launch tomorrow, September 13, during a webcasted fireside chat at 8:00 AM ET. DIFICID was approved by the U.S. Food and Drug Administration in May of 2011 for the treatment of Clostridium difficile-associated diarrhea (CDAD) in adults 18 years of age and older. CDAD is a significant medical problem in hospitals and long-term care facilities, and DIFICID is the first antibacterial drug approved for the treatment of CDAD in 25 years.

(Logo: http://photos.prnewswire.com/prnh/20090413/LA97352LOGO)

"We believe the Optimer strategy is proving highly impactful, with DIFICID sales exceeding published analyst expectations in the initial stages of the launch. While early in the launch, we view it as a major success to date. We are committed to maintaining this momentum as the launch matures," said Pedro Lichtinger, president and CEO of Optimer Pharmaceuticals. "The growing evidence of the value of DIFICID to patients, hospitals and payers  is being well received by practitioners and other stakeholders. Supported by DIFICID's clinical strength and value proposition, we believe the combined Optimer/Cubist field presence is having a material impact on accelerating prescriptions and formulary adoption."

There are several key components comprising the DIFICID launch effort and Optimer plans to review progress to date for each of those components.

1. DIFICID Sales

For the period of July 19, the date of DIFICID's first sales, through September 2 , Optimer estimates DIFICID gross sales of $
'/>"/>

SOURCE Optimer Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Optimer Pharmaceuticals DIFICID Featured in 11 Presentations at 51st ICAAC
2. Optimer Pharmaceuticals to Present at September 2011 Investor Conferences
3. Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
4. Clinical Infectious Diseases Publishes Subgroup Analysis Showing Optimers DIFICID™ (fidaxomicin) Tablets Exhibited Higher Clinical Cure and Global Cure Rates Than Vancomycin in Patients with Clostridium difficile-Associated Diarrhea (CDAD) Receivin
5. Optimer Pharmaceuticals Reports Second Quarter 2011 Financial Results
6. Optimer Launches DIFICID™ (fidaxomicin) Tablets for Treatment of Clostridium Difficile-Associated Diarrhea (CDAD) in Patients 18 Years of Age and Older
7. Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
8. Optimer Pharmaceuticals to Present at the Jefferies 2011 Global Healthcare Conference
9. Optimer Pharmaceuticals Reports First Quarter 2011 Financial Results
10. Optimer Pharmaceuticals Expands Senior Management Team
11. Optimer Pharmaceuticals to Present at May 2011 Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2014)... 21, 2014  Zacks.com announces the list of stocks featured ... analysts discuss the latest news and events impacting stocks and ... Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH - Free Report ), ... Lilly and Company (NYSE: LLY - Free Report ), ... Inc. (Nasdaq: ITMN - Free Report ). ...
(Date:7/21/2014)... Sorrento Therapeutics, Inc. (NASDAQ: SRNE ... treatments for cancer and its associated pain, today announced ... development of a small molecule inhibitor targeting the important ... protein has also been recognized as an important determinant ... as a dominant factor in most human cancers and ...
(Date:7/21/2014)...  A new Journal of the American Medical ... to appear in the August 13 print edition addresses ... C Virus (HCV) treatments such as Sovaldi (sofosbuvir) and ... (NYSE: CVS ) Chief Medical Officer Troyen ... Shrank , M.D., suggest that the discussion to this ...
Breaking Medicine Technology:The Zacks Analyst Blog Highlights: Anthera Pharmaceuticals, Amgen, Eli Lilly, Actelion and InterMune 2The Zacks Analyst Blog Highlights: Anthera Pharmaceuticals, Amgen, Eli Lilly, Actelion and InterMune 3The Zacks Analyst Blog Highlights: Anthera Pharmaceuticals, Amgen, Eli Lilly, Actelion and InterMune 4The Zacks Analyst Blog Highlights: Anthera Pharmaceuticals, Amgen, Eli Lilly, Actelion and InterMune 5The Zacks Analyst Blog Highlights: Anthera Pharmaceuticals, Amgen, Eli Lilly, Actelion and InterMune 6The Zacks Analyst Blog Highlights: Anthera Pharmaceuticals, Amgen, Eli Lilly, Actelion and InterMune 7Sorrento Awarded Grant from the National Institutes of Health for the Development of a Small Molecule Myc Inhibitor 2Sorrento Awarded Grant from the National Institutes of Health for the Development of a Small Molecule Myc Inhibitor 3Sorrento Awarded Grant from the National Institutes of Health for the Development of a Small Molecule Myc Inhibitor 4CVS Caremark JAMA Commentary: New Hepatitis C Treatments Highlight Need to Control Costs of High-Priced Specialty Medications 2CVS Caremark JAMA Commentary: New Hepatitis C Treatments Highlight Need to Control Costs of High-Priced Specialty Medications 3
... INDIANAPOLIS and ROLLING MEADOWS, Ill., April 4, 2012 ... the Diabetes Scholars Foundation (Foundation) scholarship fund. The contribution ... with type 1 diabetes to live their lives to ... fund college scholarships for students with type 1 diabetes ...
... 2012   Sunpeaks Ventures, Inc. (OTCBB: SNPK) ... its wholly owned subsidiary Healthcare Distribution Specialists, LLC ... has entered into an Agreement with Albeck Financial ... Albeck will provide outsourced Chief Financial Officer services, ...
Cached Medicine Technology:Lilly Diabetes supports Diabetes Scholars Foundation with $100,000 donation in 2012 2Lilly Diabetes supports Diabetes Scholars Foundation with $100,000 donation in 2012 3Sunpeaks Ventures Announces Agreement with Albeck Financial Services 2
(Date:7/22/2014)... (PRWEB) July 22, 2014 The ... (Short Acting, Intermediate Acting, Premixed), Modern Human Insulin ... Apidra, Levemir, NovoRapid, Novomix, Tresiba, Others) - Forecast ... major drivers, restraints, challenges, opportunities, current market trends, ... along with the estimates and forecasts of the ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 For more ... and cold storage consumers with dynamic, specialized ... and customer satisfaction. Offering 50-70% less energy requirements ... process. This process is completed through a non-chemical ... technologies also provide a 4.2 Micron droplet. The ...
(Date:7/22/2014)... Rockville, Maryland (PRWEB) July 22, 2014 ... partnership with the Immune Deficiency Foundation (IDF) ... and mobile portal that will allow them to electronically ... to better manage their illnesses. It will also allow ... in research, to consent to have their data ...
(Date:7/22/2014)... Altec Products, Inc. , a ... today their Gold Sponsorship of Sage Summit 2014 ... Hotel and Casino in Las Vegas, Nevada. The largest ... interested in taking advantage of the many opportunities to ... problems and educate themselves on the latest enterprise resource ...
(Date:7/22/2014)... Tigrent Learning Canada today announced ... estate investing workshops being held in the greater Toronto, ... introduce people to some of the strategies successful investors ... total of 9 free real estate investing workshops will ... goal is to give people in the greater Toronto ...
Breaking Medicine News(10 mins):Health News:Human Insulin Market Worth $42 Billion by 2019 - New Report by MarketsandMarkets 2Health News:Human Insulin Market Worth $42 Billion by 2019 - New Report by MarketsandMarkets 3Health News:Human Insulin Market Worth $42 Billion by 2019 - New Report by MarketsandMarkets 4Health News:Human Insulin Market Worth $42 Billion by 2019 - New Report by MarketsandMarkets 5Health News:Smart Fog Inc Announces Cold Storage Humidification Technology to be Exhibited at the 2014 Fresh Summit Convention & Expo 2Health News:Smart Fog Inc Announces Cold Storage Humidification Technology to be Exhibited at the 2014 Fresh Summit Convention & Expo 3Health News:Get Real Health to Partner with Immune Deficiency Foundation 2Health News:Get Real Health to Partner with Immune Deficiency Foundation 3Health News:Altec Announces Gold Sponsorship of Sage Summit 2014 2Health News:Altec Announces Gold Sponsorship of Sage Summit 2014 3Health News:Brick Buy Brick Announces Multiple 1-Day Real Estate Workshops Coming to Toronto 2
... of their breasts, can breathe easy now. They can raise ... their photographs . ,Visit www.myFreeimplants.com, set up a ... with other members. ,Once you have uploaded their ... can have a one-on-one chat online with benefactors and sell ...
... pair of legs in show business . ,But a ... hottest legs. ,Girls Aloud singer Nadine Coyle was voted ... ,The English all-girl group member beat other long-legged ladies ... singer Beyonce Knowles bagged the second place while troubled pop star ...
... Actor/producer Kirk Douglas admits that when it came to beautiful women ... ,The 90-year-old revealed that when he was young he ... with her. ,"The young Kirk was too interested in ... Post quoted Douglas, as saying. ,The actor revealed that ...
... law to ban circuses from importing or exporting protected ... rights, a legislator said Friday . ,Under ... imports and exports of animals such as lions, tigers, ... for research, said Tien Chiu-chin, of the ruling Democratic ...
... and money to properly treat a growing number of ... report out Friday . ,"The military system ... adequately support the psychological health of service members and ... year-long Pentagon mental health task force report: "An Achievable ...
... year in Sierra Leone's capital Freetown last year has been ... health worker attributed the fall in rabies cases to a ... the main referral Connaught Hospital are worried about a lack ... hospital has had to rely heavily on anti-rabies drug handouts ...
Cached Medicine News:Health News:Website Offers to Help Women Raise Money for Breast Enhancement 2Health News:War Veterans Lack Adequate Mental Health Care: Pentagon Report 2
... LV lead is designed to ensure ... procedure times, delivering a complete package ... QuickSite LV lead is a highly ... including such features as S-shaped fixation, ...
... Tibial Nail System is designed ... of existing implants and expand ... nails. It is available in ... and lengths and can be ...
Arthroscopic instrument system for instability and SLAP fixation....
Arthroscopic instrument system for instability and SLAP fixation....
Medicine Products: